Room A207
16:30 – 18:30

Chairs: Martin O. Leach and Nicholas Van Bruggen

16:30  99.  Assessment of Tumor Angiogenesis by Contrast-Enhanced MRI: A Novel MR Probe for In Vivo Correlation of Intravital and Magnetic Resonance Microscopy, J. Griebel, M. Brandl, S.A. Pahernik, A. Goetz, G. Brix and M. Dellian, Federal Office for Radiation Protection and GSF Research Center, Neuherberg, Germany and University of Munich, Munich, Germany.
16:42  100.  In vivo NMR Imaging of Microvascularization in Normal Rat Brain and in Rat Brain Tumors, C. Rémy, I. Troprès, M. Péoc'h, R. Farion and M. Décorps, Université Joseph Fourier, Grenoble, France.
16:54  101.  Vascular Characterization of Human Breast Cancer and Prostate Cancer Models, Z.M. Bhujwalla, D. Artemov and M. Solaiyappan, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
17:06  102.  Radiation Induced Tumor Vascular Volume and Vascular Permeability Changes Measured by Contrast Enahnced MRI: A Longitudinal Study, H. Yu, M-Y. Su, Z. Wang and O. Nalcioglu, University of California, Irvine, CA, USA.
17:18  103.  Vascular Permeability is Correlated with Susceptibility to Combretastatin A4 Phosphate in Four Tumor Models, D.A. Beauregard, S.A. Hill, D.J. Chaplin and K.M. Brindle, University of Cambridge, Cambridge, UK and Gray Laboratory Cancer Research Trust, Middlesex, UK.
17:30  104.   MR Imaging for Monitoring Altered Microvascular Permeability and Ascites Volume in Ovarian Cancer Following Treatment with Antibody to Vascular Endothelial Growth Factor, A. Gossmann, T.H. Helbich, S. Mesiano, D.M. Shames, M.F. Wendland, T.P.L. Roberts, N. Ferrara, R. Jaffe and R.C. Brasch, University of California San Francisco, CA, USA; University of Cologne, Cologne, Germany and Genentech Inc., South San Francisco, CA, USA.
17:42  105.  MRI Quantitation of Sustained VEGF Induced Blood-Retinal Barrier Breakdown: A Rabbit Study, N. Alikacem, T. Yoshizawa, C. Wilson and K. Nelson, University of Texas Southwestern Medical Center, Dallas, TX, USA; University of Texas, Arlington, TX, USA and Niigata University, Niigata, Japan.
17:54  106.  Evaluation of Ischemia-Driven Angiogenesis in a Rat Model of Peripheral Arterial Insufficiency:
J.M. Greve, S.P. Williams, H. Steinmetz, S. Bunting, L. Bernstein and N. van Bruggen, Genentech Inc., South San Francisco, CA, USA.
18:06  107.  Ultrafast Quantitative 3D Mapping of Blood Volume and Endothelial Permeability in Brain Tumours, K.L. Li, X.P. Zhu, J.C. Waterton and A. Jackson, University of Manchester, Manchester, UK and AstraZeneca, Macclesfield, Cheshire, UK.
18:18  108.  Changes In Tumour Vascular Permeability With Antiangiogenesis Therapy - Observations on Histogram Analysis, A.R. Padhani, A. O'Donell, C. Hayes, I. Judson, P. Workman, A. Hannah, M.O. Leach and J.E. Husband, Institute of Cancer Research and The Royal Marsden NHS Trust, Sutton, Surrey, UK and Sugen Inc., San Francisco, CA, USA.

Return to ISMRM program